Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by boazklinghornon Sep 08, 2023 10:48am
75 Views
Post# 35626074

RE:A key question...

RE:A key question...Heres an idea .Gilles has no idea how reverse take overs even work. The listed comopany is smaller than the company seeking the listing and issues enough shares to aquire the nonlisted company so that the controling interestes of the private co are now the controling shareholders of the combined entity and gone from private to listed. In order for this to work they would need to find a very small like microscopically small listed co. if the market cap of the aquiribng company was larger than 30MM Canadian then the listed company after issuing shares to aquire Ceapro would remain in control of the combined entity. 
Not a secutites lawyer but it seems a difficult hurdle. 
Better idea is to grow the current business and leave Nasdaq to the big boys until they have the financial firepower to legitimatley uplist. THis is typical Gilles and co trying to fail their way to success by attepting financial engineering that is clearly beyond the scope of the Ceapro braintrust. 
Lets get us a real CEO who can actually build a business by creating and selling products the market wants. 
<< Previous
Bullboard Posts
Next >>